Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Moolec Science SA Ordinary Shares
MLEC | US
7.11
USD-1.00
-12.33%
MLEC | US
About Moolec Science SA Ordinary Shares
Sector
Healthcare
Industry
Biotechnology
Earnings date
31/03/2024
As of date
10/04/2026
Close
7.11
Open
7.82
High
7.99
Low
7.11
Moolec Science SA a science-based food ingredient company focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC a dairy ingredient; GLA SONOVA a nutritional oil; POORK+ a plant-based animal meat free ingredient with porcine proteins in soybeans; and BEEF+ a meat replacement product. It operates in the United States Europe and South America. The company was founded in 2020 and is based in Luxembourg.
View LessMLEC | US
Risk
262.9
Sharpe
-0.47
Luna's Score
36/100
Recommendation
Sell
Luna says (MLEC | US)
What's Working
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
374.1%1 month
262.9%3 months
370.4%6 months
275.5%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.67
Debt to equity
2.09
Debt to assets
0.54
Ent. to EBITDA
-1.01
Ent. to rev.
7.37
PEG
-
Other Fundamentals
EBITDA
-8.18M
MarketCap
266.34M
MarketCap(USD)
266.34M
Div. yield
-
Op. margin
-193.02
Erngs. growth
-
Rev. growth
68.30
Ret. on equity
-86.42
Short ratio
7.65
Short perc.
3.31
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
6.35
Range1M
7.01
Range3M
19.82
Volumes: Market Activity
Rel. volume
0.06
Price X volume
227.87K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.01 | - | Cheaper |
| Ent. to Revenue | 7.37 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.67 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 370.36 | - | Riskier |
| Debt to Equity | 2.09 | -1.23 | Expensive |
| Debt to Assets | 0.54 | 0.25 | Expensive |
| Market Cap | 266.34M | - | Emerging |
